The Financial Checklist for SNF Acquisition Due Diligence: 12 Revenue Cycle Questions to Ask

The first 100 days after an SNF acquisition are often framed as an integration challenge: retain staff, stabilize census, meet payroll, transition vendors, and satisfy change-of-ownership requirements.

But the financial outcome of the deal may already be embedded in one less visible asset: the seller’s revenue cycle.

The buyer inherits more than occupied beds, a census report, and a trailing-twelve-month EBITDA figure. It may inherit aged receivables with uncertain recovery, payer contracts that do not support the underwriting model, unresolved Medicare or Medicaid matters, undocumented authorization practices, missing MDS support, billing staff who may exit at closing, and a cash-conversion process that breaks as soon as the prior owner’s team leaves.

That is why SNF acquisition revenue cycle due diligence is not a back-office review performed after valuation. It is a deal-protection workstream that should influence price, working-capital targets, representations and warranties, indemnification, transition services, and the first 100-day operating plan.

A seller’s financial statements show what the facility reported. Revenue-cycle due diligence tests whether the reported revenue is collectible, supportable, repeatable, and transferable after closing.

SNF Revenue Cycle Due Diligence Changes the Deal Model

Traditional financial diligence asks whether historical revenue, expenses, census, labor, and cash flow reconcile.

Revenue-cycle diligence asks a different set of questions:

• Is the reported A/R collectible at its recorded amount?
• Which balances belong to a valid payer path, and which are likely adjustments or write-offs?
• Are claims supported by authorization, documentation, MDS, and billing records?
• Is the payer mix producing sustainable net revenue?
• Are managed-care contract terms compatible with the buyer’s operating model?
• Are there audit findings, overpayment matters, repayment obligations, or unresolved disputes?
• Can the billing function continue on day one after closing?
• What revenue leakage can be recovered—and what risk must be priced into the transaction?

This matters in a Medicare provider change of ownership. CMS explains that a typical CHOW occurs when a Medicare provider is purchased or leased by another organization and may involve the transfer of the prior owner’s Medicare provider agreement and Medicare identification number, including outstanding Medicare debt (Read CMS Form 855A). SNF buyers and sellers must also report applicable ownership transactions to CMS, and SNFs undergoing CHOW use the CMS-855A process and SNF Attachment requirements (Read CMS’s SNF Attachment guidance).

The precise legal, reimbursement, successor-liability, enrollment, and contract consequences depend on transaction structure, state rules, payer contracts, and the facts of the deal. Buyers should involve qualified transaction counsel, reimbursement advisors, enrollment specialists, and financial advisors early.

1. Is the SNF Accounts Receivable Real, Collectible, and Properly Reserved?

The A/R aging report is not simply a balance-sheet schedule. It is a probability-weighted view of future cash.

Request an account-level A/R aging report by payer and resident responsibility category, segmented at least into:

• 0–30 days.
• 31–60 days.
• 61–90 days.
• 91–120 days.
• More than 120 days.

Then ask the seller to explain the balances—not just total them.

Do not accept an answer such as “the biller is following up.” Require account-level status, a documented next action, the last action date, and evidence of the claimed recovery path.

A large 120+-day balance is not automatically worthless. It may contain high-value claims with a live appeal, eligibility, or payer-resolution path. But a balance should not be valued as fully collectible simply because it remains on the ledger.

Deal-model impact

A/R diligence should feed into:

• Working-capital peg calculations.
• A/R purchase-price adjustments.
• Specific reserves or exclusions.
• Escrow decisions.
• Collection rights and post-close recovery allocation.
• Seller cooperation obligations after closing.
• The buyer’s first-100-day collection plan.

2. What Does the SNF Clean-Claim Performance Reveal?

A clean claim is generally a claim that can be processed without avoidable correction, missing information, or payer intervention. The exact payer definition varies, so buyers should request the seller’s calculation methodology before relying on the metric.

Do not use a generic “90% is good” threshold without considering payer mix, claim complexity, system configuration, and how the seller defines first-pass acceptance.

Instead, ask:

• How does the facility define a clean claim?
• Is the measure based on claim acceptance, first-pass adjudication, paid claims, or absence of rework?
• Which payers are included?
• Is the data measured by claim count, claim dollars, or both?
• Has the rate improved or deteriorated during the past 12–24 months?
• Which claims fail first-pass processing most often?
• Are claims rejected by the clearinghouse, payer, or internal billing review?
• How much staff time is spent on rework?

What low first-pass performance can indicate

• Incorrect eligibility or payer setup.
• Missing or inaccurate authorizations.
• Incomplete documentation workflow.
• Late or inconsistent MDS transmission.
• Coding or claim-format errors.
• Outdated payer configuration.
• Billing-staff training gaps.
• Weak claim-edit controls.
• Fragmented clinical, MDS, billing, and A/R systems.

Clean-claim performance does not determine deal value by itself. It is an early indicator of how much revenue-cycle remediation, staffing support, and cash-flow protection the buyer may need immediately after closing.

3. Which SNF Denials Are Operational Errors—and Which Are Structural Risks?

A denial report is only useful if it is broken down by payer, denial reason, dollars, aging, appeal status, and final resolution.

Request at least 12–24 months of denial data and identify the top denial categories by both claim count and denied dollars.

For each major denial category, ask:

• Is the claim appealed, corrected, resubmitted, adjusted, or written off?
• What is the recovery rate?
• How long does resolution take?
• What is the current outstanding exposure?
• Has the root cause been corrected?
• Does the seller track denials by plan and facility?
• Does the facility have a defined escalation path for high-dollar or repeated denials?

The buyer is not only evaluating historical collections. The buyer is identifying the operational defects that could continue after the transaction.

4. Are Medicare, Medicaid, or Managed-Care Liabilities Fully Disclosed?

A diligence request should seek more than a general representation that the facility has “no known audits.”

Request copies of:

• Medicare Administrative Contractor correspondence.
• Medicare overpayment notices.
• Unified Program Integrity Contractor and other program-integrity correspondence.
• State Medicaid audit, desk-review, and program-integrity notices.
• Managed-care audit findings and recoupment notices.
• Repayment plans and settlement agreements.
• Self-disclosures, if applicable.
• Appeals, reconsiderations, and open disputes.
• Demand letters, repayment requests, and related reserve calculations.
• Internal compliance audits and corrective-action plans.
• Legal notices involving billing, reimbursement, or payer conduct.

This is not theoretical risk. HHS OIG has reported SNF audit findings involving claims that did not comply with Medicare requirements and associated estimated overpayments. In one OIG audit, 99 of 100 sampled skilled nursing services claims did not comply with Medicare requirements, with the audit estimating at least $31.2 million in overpayments for the audit period (Read the HHS OIG SNF reimbursement audit).

An OIG audit finding at another provider is not evidence that the target facility has a problem. It is a reminder that billing, coverage, documentation, and payment controls deserve deal-level scrutiny.

Deal protections to discuss with counsel

Potential concerns may affect:

• Disclosure schedules.
• Purchase-price adjustment mechanisms.
• Escrows and holdbacks.
• Specific indemnification provisions.
• Survival periods.
• Pre-close corrective-action obligations.
• Post-close cooperation requirements.
• Allocation of recoveries, refunds, recoupments, and legal costs.

Transaction counsel should determine the appropriate provisions for the deal. The financial diligence team should quantify the exposure and preserve the evidence.

5. Is the Payer Mix Stable, Valuable, and Transferable?

Payer mix should be assessed as a trend, not a single month-end percentage.

Request 24–36 months of payer days, admissions, discharges, net revenue per patient day, A/R, and payment data by:

• Original Medicare Part A.
• Medicare Advantage, by plan.
• Medicaid fee-for-service.
• Medicaid managed care, by plan.
• Private pay.
• Commercial and other payers.
• Hospice and other relevant payment arrangements.

Then ask whether the mix supports the underwriting assumptions.

Payer mix diligence questions

• Is Original Medicare volume stable, rising, or declining?
• Which managed-care plans are gaining or losing volume?
• Is Medicaid growth driven by strategy, market changes, declining post-acute referrals, or census pressure?
• Has private-pay volume changed because of market position, pricing, resident conversion, or collection issues?
• Are high-value payer days concentrated in one referral source, hospital, or plan?
• Does a payer’s revenue contribution exceed the administrative, authorization, denial, and collection burden it creates?
• Are payer contracts assignable, renewable, or at risk following a change of ownership?
• Are there referral relationships that may change after closing?

A payer category is not inherently good or bad. The relevant measure is the facility’s actual net contribution and risk profile by payer and plan.

6. Do Medicare Advantage and Managed Medicaid Contracts Support the Underwriting Case?

A contract inventory should be a core diligence deliverable.

Request all active and recently terminated contracts for Medicare Advantage, managed Medicaid, commercial insurance, accountable-care arrangements, therapy, pharmacy, transportation, and other arrangements that affect revenue or resident cost.

For every managed-care contract, review:

The buyer should not assume that a contract rate will remain available after acquisition. CHOW, ownership changes, provider enrollment, credentialing, network policy, plan discretion, and contract language can all affect the relationship.

CMS’s Medicare Advantage rules provide certain appeal structures for applicable organization determinations, but a provider payment dispute is not always the same as an enrollee coverage appeal. Review plan rules and contract provisions separately for authorization, clinical coverage, claim-payment, and in-network contractual disputes (Read CMS’s Medicare Advantage appeals overview).

7. Does PDPM Data Reflect Documentation Strength or Revenue Risk?

PDPM classifies residents in covered Medicare Part A SNF stays using case-mix classification components. CMS implemented PDPM for SNF PPS classification effective October 1, 2019 (Read CMS’s PDPM overview).

During acquisition diligence, do not reduce PDPM review to one average CMI number.

Ask for trends in:

• Medicare Part A admissions and covered days.
• PDPM case-mix components.
• Case-mix index trends.
• MDS completion and transmission timeliness.
• Significant assessment corrections.
• Interrupted-stay patterns.
• Non-therapy ancillary classifications.
• IPA utilization, where relevant.
• Medicare rate adjustments.
• Clinical documentation supporting key classifications.
• Comparative performance by facility, referral source, and period.

The key diligence question

Does the target’s PDPM performance reflect its true clinical population and documentation practices, or is there an unexamined coding, workflow, or compliance issue?

A lower case mix may represent a lower-acuity population, a referral-pattern issue, incomplete clinical capture, or an MDS process opportunity. A higher case mix may reflect genuine resident acuity, but it also requires documentation support and compliance review.

Buyers should avoid treating every variation from a benchmark as “revenue upside.” PDPM optimization must be clinically supported, accurately documented, and compliant with applicable requirements.

8. What Is the Status of State Medicaid Cost Reports, Settlements, and Audits?

Medicaid cost-report forms, state reimbursement methods, settlement practices, audit procedures, and appeal rights vary by state.

Request:

• Filed state Medicaid cost reports for the prior three to five years, as appropriate.
• State rate notices and rate-calculation support.
• Cost-report workpapers and reconciliations.
• Desk-review and field-audit correspondence.
• Open information requests.
• Settlement notices, receivable notices, and payable notices.
• Related-party disclosures.
• Management-fee, lease, and home-office documentation.
• Any open reconsideration, appeal, or rate-review matter.
• Status of incomplete or overdue filings.

Medicare-certified institutional providers submit annual cost reports, and SNF cost-report data is submitted to HCRIS using CMS-2540-2010 (Read CMS’s SNF cost-report methodology). State Medicaid programs may also use statewide nursing-facility cost-report data for Medicaid payment and related purposes (Read CMS’s Medicaid nursing-facility narrative instructions).

The buyer should identify whether a settlement, repayment exposure, rate adjustment, or audit result belongs economically to the pre-close or post-close period and address that allocation in the transaction documents.

9. Is the MDS Process Accurate, Timely, and Operationally Controlled?

MDS data affects resident assessment, quality reporting, care planning, and SNF Medicare payment classification. It should be evaluated as a clinical, reimbursement, and compliance process.

Request:

• MDS completion and transmission reports.
• Late-assessment and late-transmission reports.
• Correction and modification activity.
• Internal MDS audit results.
• External review findings.
• Assessment staffing structure and turnover history.
• MDS coordinator workload and coverage plan.
• Documentation support for high-impact assessment areas.
• Communication workflow among nursing, therapy, providers, MDS, billing, and finance.
• Corrected claims or payment adjustments tied to MDS activity.

MDS red flags in an SNF acquisition

• High rate of late or corrected assessments.
• One person controlling the MDS function without backup coverage.
• Frequent turnover in MDS leadership.
• Significant difference between clinical records and assessment support.
• Unexplained PDPM case-mix shifts.
• Billing delays tied to assessment completion.
• Repeated claim adjustments or payer inquiries.
• No documented internal audit process.

The goal is not to identify theoretical coding upside. It is to determine whether the assessment and documentation process can withstand operational transition, payer review, and post-close volume changes.

10. What Does DSO Reveal About Cash Conversion?

Days sales outstanding, or DSO, estimates how long it takes the facility to convert billed revenue into cash.

A common calculation is:

DSO = Ending Gross Accounts Receivable ÷ Average Daily Gross Revenue

For acquisition diligence, DSO should be reviewed by the payer, not only as a total-facility metric.

A blended DSO can hide:

• Timely Original Medicare payment alongside slow managed-care collection.
• Growing Medicaid-pending balances.
• Private-pay collection failure.
• Underpayment or rate-configuration issues.
• Posting backlogs.
• Denial volume masked by current claims.

Avoid using a universal “good” or “bad” DSO benchmark. The appropriate range depends on payer mix, state Medicaid cycle time, managed-care contracts, billing cadence, resident-responsibility workflow, and claim complexity.

Instead, compare:

• Current DSO with trailing 12-, 24-, and 36-month trends.
• DSO by payer and plan.
• A/R aging movement.
• Gross versus net A/R.
• Credit-balance movement.
• Cash collections relative to billed charges and expected revenue.
• Staff workload and unresolved claim inventory.

A worsening DSO trend may be one of the earliest signals that the buyer’s opening cash forecast needs adjustment.

11. Does the Target Have Billing, Reimbursement, or Compliance Exposure?

Request a formal legal and compliance disclosure process for:

• Government investigations.
• OIG inquiries.
• False Claims Act allegations or litigation.
• Medicare or Medicaid program-integrity reviews.
• Provider enrollment issues.
• Exclusion-screening failures.
• Whistleblower complaints involving billing or reimbursement.
• Payer fraud-and-abuse inquiries.
• Quality or documentation matters with reimbursement implications.
• Billing-related settlements.
• Material demand letters and threatened claims.

The due diligence team should also review whether the facility has maintained a functioning compliance process:

• Written policies.
• Staff training.
• Internal audits.
• Corrective-action plans.
• Documentation retention.
• Issue escalation.
• Board or ownership oversight.
• Reporting and investigation processes.

Do not treat the absence of disclosed litigation as proof that no risk exists. Test the billing and documentation processes that could generate future exposure.

The buyer’s legal team should determine how representations, warranties, indemnities, disclosure schedules, escrows, and compliance conditions should address identified risks.

12. Can Billing Continue Without Disrupting Day-One Cash Flow?

The transaction may close successfully and still create a revenue-cycle disruption if billing knowledge, payer access, system credentials, clearinghouse connectivity, documentation workflow, or staff coverage does not transfer smoothly.

Map the billing operating model before closing.

Billing continuity diligence checklist

A post-close transition plan should identify account ownership for every open receivable, payer portal, appeal, claim correction, payment source, and unresolved authorization.

LTCPro provides long-term care billing, authorization, payment posting, denial, A/R, payroll, AP, resident trust, and financial workflows that help buyers stabilize revenue-cycle operations during transition. When a transaction requires billing continuity or rapid operational visibility, LTCPro can establish structured payer work queues, account-level A/R ownership, claim and denial tracking, payment posting controls, and management reporting from day one.

Turn Findings Into Deal Terms and a 100-Day Plan

Revenue-cycle diligence should not end with a spreadsheet of findings.

Each finding should become one of four things:

A practical SNF acquisition revenue-cycle workstream

Before signing

• Obtain preliminary A/R, payer, denial, contract, and compliance data.
• Identify deal-breaker risks and valuation assumptions.
• Define the data room request list.
• Determine specialist diligence needs.

Between signing and closing

• Complete account-level A/R analysis.
• Review payer contracts and CHOW provisions.
• Confirm Medicare enrollment and ownership-reporting steps.
• Assess MDS, PDPM, billing, and authorization workflow.
• Quantify open audits, recoupments, and pending settlements.
• Build a day-one access and staffing plan.

First 30 days after closing

• Stabilize claim submission and payment posting.
• Confirm payer portal and clearinghouse access.
• Assign ownership of all open A/R and appeals.
• Reconcile cash, remittances, claim status, and credit balances.
• Track transition-related claim and authorization exceptions daily.

Days 31–100 after closing

• Resolve priority aged A/R.
• Correct high-frequency denial root causes.
• Review plan-specific MA performance.
• Validate payer setup, rates, and contract terms.
• Strengthen MDS-to-billing handoffs.
• Establish payer, A/R, denial, and cash-performance dashboards.

What LTCPro Delivers During SNF Acquisition Transition

LTCPro supports the revenue-cycle work that buyers need before and after an SNF transaction.

The LTCPro workflow environment supports:

• Insurance verification and payer setup.
• Medicare, Medicare Advantage, Medicaid, managed Medicaid, and private-pay billing.
• Authorization and continued-stay tracking.
• Claims submission, correction, denial work, and payer follow-up.
• Payment posting and remittance analysis.
• Underpayment and contract-variance identification.
• Payer-specific A/R management.
• Medicaid-pending and resident-responsibility tracking.
• Financial, AP, payroll, resident-trust, census, and revenue-cycle reporting.
• Operational dashboards for ownership, finance, and facility leadership.

For buyers, this creates a disciplined transition model: each open receivable has a payer path, account owner, documentation record, next action, and escalation process rather than becoming an inherited balance with no operational accountability.

Frequently Asked Questions

What is SNF acquisition revenue-cycle due diligence?

SNF acquisition revenue-cycle due diligence is the review of billing, accounts receivable, payer contracts, authorizations, denials, payment processes, MDS-related reimbursement workflow, compliance exposure, and operational continuity before an acquisition closes. It complements financial-statement, legal, clinical, real-estate, and regulatory diligence.

Why is A/R quality important in an SNF acquisition?

The recorded A/R balance may include valid pending claims, appealed denials, Medicaid-pending accounts, underpayments, resident balances, credit balances, and uncollectible debt. Account-level analysis helps a buyer determine which receivables are likely to convert to cash and which require reserves, purchase-price adjustments, exclusions, or post-close collection plans.

What should a buyer review in SNF Medicare Advantage contracts?

Review network status, reimbursement methodology, rate exhibits, authorization and continued-stay requirements, ancillary-service responsibility, claim-filing rules, denial and dispute processes, recoupment provisions, assignment or CHOW terms, credentialing requirements, renewal terms, and termination rights.

Does a Medicare provider CHOW affect outstanding Medicare debt?

CMS states that a typical change of ownership can transfer the seller’s Medicare provider agreement and Medicare identification number to the new owner, including outstanding Medicare debt. The effect of a specific transaction depends on its structure and facts, so buyers should evaluate CHOW matters with qualified legal, reimbursement, and enrollment advisors (Read CMS Form 855A).

What is the biggest revenue-cycle risk after an SNF acquisition?

There is no single universal risk. Common post-close threats include uncollectible inherited A/R, missing payer or portal access, billing-staff turnover, unresolved authorizations, incorrect payer setup, unmanaged Medicare Advantage denials, incomplete MDS-to-billing workflow, unrecognized audit exposure, and delayed payment posting. A detailed transition plan reduces the likelihood that these issues interrupt cash flow after closing.